US Stock MarketDetailed Quotes

WVE Wave Life Sciences

Watchlist
  • 6.160
  • +0.070+1.15%
Trading May 24 10:33 ET
754.35MMarket Cap-12078P/E (TTM)

Wave Life Sciences Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-139.09%-33.43M
84.79%-19.43M
0.60%-33.24M
-34.36%-34.46M
-29.27%-37.26M
314.49%85.52M
-43.59%-127.78M
-375.47%-33.44M
9.01%-25.65M
-206.58%-28.82M
Net income from continuing operations
-15.15%-31.56M
64.46%-57.51M
62.81%-16.26M
118.59%7.25M
48.90%-21.1M
27.53%-27.41M
-32.38%-161.82M
-25.65%-43.71M
-526.07%-39M
-6.53%-41.3M
Operating gains losses
----
----
----
----
----
----
--12K
----
----
----
Depreciation and amortization
-10.71%2.18M
-8.98%9.21M
-12.55%2.18M
-12.96%2.26M
-7.27%2.32M
-3.02%2.44M
2.84%10.11M
-1.69%2.5M
8.51%2.6M
2.62%2.5M
Change In working capital
-106.43%-6.93M
183.86%19.08M
-543.19%-21.52M
-725.86%-46.26M
-791.52%-20.88M
1,360.99%107.74M
-4.11%6.72M
-77.41%4.86M
124.44%7.39M
-87.52%3.02M
-Change in receivables
--21.09M
---21.09M
---14.09M
----
----
--0
--0
--0
----
----
-Change in prepaid assets
5.54%-1.23M
-46.88%-1.98M
-367.45%-2.4M
174.05%1.5M
-85.82%219K
-264.89%-1.3M
-135.01%-1.35M
-149.19%-513K
-229.60%-2.02M
24.32%1.54M
-Change in payables and accrued expense
22.80%-11.28M
-137.25%-4.49M
-41.44%4.4M
-46.51%2.7M
-38.64%3.03M
-168.36%-14.6M
427.41%12.04M
129.92%7.51M
1,312.89%5.04M
423.70%4.93M
-Change in other current assets
22.73%-1.39M
-159.22%-2.01M
183.49%91K
-95.01%272K
48.04%-569K
-111.99%-1.8M
1,104.14%3.39M
92.13%-109K
20.50%5.45M
37.78%-1.1M
-Change in other current liabilities
-58.08%-1.58M
-38.08%-5.69M
-95.83%-1.55M
-81.36%-1.68M
30.46%-1.45M
-222.19%-1M
5.57%-4.12M
63.55%-791K
-251.52%-928K
-113.06%-2.09M
-Change in other working capital
-109.92%-12.54M
1,774.21%54.33M
-543.34%-7.97M
-27,742.38%-42.04M
-8,057.56%-22.11M
8,082.83%126.45M
82.43%-3.25M
29.80%-1.24M
98.92%-151K
---271K
Cash from discontinued investing activities
Operating cash flow
-139.09%-33.43M
84.79%-19.43M
0.60%-33.24M
-34.36%-34.46M
-29.27%-37.26M
314.49%85.52M
-43.59%-127.78M
-375.47%-33.44M
9.01%-25.65M
-206.58%-28.82M
Investing cash flow
Cash flow from continuing investing activities
14.72%-417K
11.16%-1.12M
-101.43%-356K
60.48%-198K
-100.29%-72K
99.03%-489K
-124.11%-1.26M
165,700.00%24.84M
-411.22%-501K
7,360.77%24.61M
Net PPE purchase and sale
14.72%-417K
11.16%-1.12M
-74.51%-356K
56.67%-198K
81.35%-72K
-135.10%-489K
-124.11%-1.26M
-1,260.00%-204K
-366.33%-457K
-13.86%-386K
Net investment purchase and sale
----
--0
--0
--0
----
----
--0
--25.04M
---44K
--25M
Cash from discontinued investing activities
Investing cash flow
14.72%-417K
11.16%-1.12M
-101.43%-356K
60.48%-198K
-100.29%-72K
99.03%-489K
-124.11%-1.26M
165,700.00%24.84M
-411.22%-501K
7,360.77%24.61M
Financing cash flow
Cash flow from continuing financing activities
-58.61%14.51M
97.26%132.53M
170,740.00%93.96M
9,723.53%1.67M
-97.19%1.85M
2,563.60%35.05M
20.35%67.19M
-99.84%55K
-99.80%17K
1,204.26%65.8M
Net common stock issuance
-59.45%14.04M
150.89%131.28M
121,624.68%93.57M
888.02%1.32M
-96.57%1.76M
3,033.30%34.62M
-4.81%52.33M
-100.23%-77K
-102.08%-167K
920.10%51.46M
Proceeds from stock option exercised by employees
9.77%472K
-91.54%1.26M
193.94%388K
92.39%354K
-99.41%85K
103.79%430K
1,632.28%14.86M
--132K
-42.86%184K
--14.34M
Cash from discontinued financing activities
Financing cash flow
-58.61%14.51M
97.26%132.53M
170,740.00%93.96M
9,723.53%1.67M
-97.19%1.85M
2,563.60%35.05M
20.35%67.19M
-99.84%55K
-99.80%17K
1,204.26%65.8M
Net cash flow
Beginning cash position
121.42%204.05M
-40.24%92.16M
42.76%143.63M
39.29%176.64M
224.68%212.22M
-40.24%92.16M
-18.04%154.22M
-21.12%100.61M
-14.02%126.81M
-57.05%65.36M
Current changes in cash
-116.10%-19.34M
281.07%111.99M
806.46%60.37M
-26.23%-32.99M
-157.60%-35.48M
235.29%120.09M
-83.39%-61.85M
-131.95%-8.55M
-31.09%-26.13M
1,411.86%61.59M
Effect of exchange rate changes
-252.38%-74K
54.76%-95K
-38.30%58K
57.89%-32K
29.58%-100K
75.58%-21K
-0.96%-210K
222.08%94K
-590.91%-76K
---142K
End cash Position
-13.00%184.64M
121.42%204.05M
121.42%204.05M
42.76%143.63M
39.29%176.64M
224.68%212.22M
-40.24%92.16M
-40.24%92.16M
-21.12%100.61M
-14.02%126.81M
Free cash flow
-139.81%-33.85M
84.09%-20.55M
0.15%-33.6M
-32.76%-34.66M
-27.34%-37.33M
312.15%85.03M
-44.21%-129.14M
-377.36%-33.64M
7.70%-26.1M
-200.97%-29.31M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -139.09%-33.43M84.79%-19.43M0.60%-33.24M-34.36%-34.46M-29.27%-37.26M314.49%85.52M-43.59%-127.78M-375.47%-33.44M9.01%-25.65M-206.58%-28.82M
Net income from continuing operations -15.15%-31.56M64.46%-57.51M62.81%-16.26M118.59%7.25M48.90%-21.1M27.53%-27.41M-32.38%-161.82M-25.65%-43.71M-526.07%-39M-6.53%-41.3M
Operating gains losses --------------------------12K------------
Depreciation and amortization -10.71%2.18M-8.98%9.21M-12.55%2.18M-12.96%2.26M-7.27%2.32M-3.02%2.44M2.84%10.11M-1.69%2.5M8.51%2.6M2.62%2.5M
Change In working capital -106.43%-6.93M183.86%19.08M-543.19%-21.52M-725.86%-46.26M-791.52%-20.88M1,360.99%107.74M-4.11%6.72M-77.41%4.86M124.44%7.39M-87.52%3.02M
-Change in receivables --21.09M---21.09M---14.09M----------0--0--0--------
-Change in prepaid assets 5.54%-1.23M-46.88%-1.98M-367.45%-2.4M174.05%1.5M-85.82%219K-264.89%-1.3M-135.01%-1.35M-149.19%-513K-229.60%-2.02M24.32%1.54M
-Change in payables and accrued expense 22.80%-11.28M-137.25%-4.49M-41.44%4.4M-46.51%2.7M-38.64%3.03M-168.36%-14.6M427.41%12.04M129.92%7.51M1,312.89%5.04M423.70%4.93M
-Change in other current assets 22.73%-1.39M-159.22%-2.01M183.49%91K-95.01%272K48.04%-569K-111.99%-1.8M1,104.14%3.39M92.13%-109K20.50%5.45M37.78%-1.1M
-Change in other current liabilities -58.08%-1.58M-38.08%-5.69M-95.83%-1.55M-81.36%-1.68M30.46%-1.45M-222.19%-1M5.57%-4.12M63.55%-791K-251.52%-928K-113.06%-2.09M
-Change in other working capital -109.92%-12.54M1,774.21%54.33M-543.34%-7.97M-27,742.38%-42.04M-8,057.56%-22.11M8,082.83%126.45M82.43%-3.25M29.80%-1.24M98.92%-151K---271K
Cash from discontinued investing activities
Operating cash flow -139.09%-33.43M84.79%-19.43M0.60%-33.24M-34.36%-34.46M-29.27%-37.26M314.49%85.52M-43.59%-127.78M-375.47%-33.44M9.01%-25.65M-206.58%-28.82M
Investing cash flow
Cash flow from continuing investing activities 14.72%-417K11.16%-1.12M-101.43%-356K60.48%-198K-100.29%-72K99.03%-489K-124.11%-1.26M165,700.00%24.84M-411.22%-501K7,360.77%24.61M
Net PPE purchase and sale 14.72%-417K11.16%-1.12M-74.51%-356K56.67%-198K81.35%-72K-135.10%-489K-124.11%-1.26M-1,260.00%-204K-366.33%-457K-13.86%-386K
Net investment purchase and sale ------0--0--0----------0--25.04M---44K--25M
Cash from discontinued investing activities
Investing cash flow 14.72%-417K11.16%-1.12M-101.43%-356K60.48%-198K-100.29%-72K99.03%-489K-124.11%-1.26M165,700.00%24.84M-411.22%-501K7,360.77%24.61M
Financing cash flow
Cash flow from continuing financing activities -58.61%14.51M97.26%132.53M170,740.00%93.96M9,723.53%1.67M-97.19%1.85M2,563.60%35.05M20.35%67.19M-99.84%55K-99.80%17K1,204.26%65.8M
Net common stock issuance -59.45%14.04M150.89%131.28M121,624.68%93.57M888.02%1.32M-96.57%1.76M3,033.30%34.62M-4.81%52.33M-100.23%-77K-102.08%-167K920.10%51.46M
Proceeds from stock option exercised by employees 9.77%472K-91.54%1.26M193.94%388K92.39%354K-99.41%85K103.79%430K1,632.28%14.86M--132K-42.86%184K--14.34M
Cash from discontinued financing activities
Financing cash flow -58.61%14.51M97.26%132.53M170,740.00%93.96M9,723.53%1.67M-97.19%1.85M2,563.60%35.05M20.35%67.19M-99.84%55K-99.80%17K1,204.26%65.8M
Net cash flow
Beginning cash position 121.42%204.05M-40.24%92.16M42.76%143.63M39.29%176.64M224.68%212.22M-40.24%92.16M-18.04%154.22M-21.12%100.61M-14.02%126.81M-57.05%65.36M
Current changes in cash -116.10%-19.34M281.07%111.99M806.46%60.37M-26.23%-32.99M-157.60%-35.48M235.29%120.09M-83.39%-61.85M-131.95%-8.55M-31.09%-26.13M1,411.86%61.59M
Effect of exchange rate changes -252.38%-74K54.76%-95K-38.30%58K57.89%-32K29.58%-100K75.58%-21K-0.96%-210K222.08%94K-590.91%-76K---142K
End cash Position -13.00%184.64M121.42%204.05M121.42%204.05M42.76%143.63M39.29%176.64M224.68%212.22M-40.24%92.16M-40.24%92.16M-21.12%100.61M-14.02%126.81M
Free cash flow -139.81%-33.85M84.09%-20.55M0.15%-33.6M-32.76%-34.66M-27.34%-37.33M312.15%85.03M-44.21%-129.14M-377.36%-33.64M7.70%-26.1M-200.97%-29.31M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg